Papers

12

Total Citations

229

H-Index

9

About

Dr. Matthias Oelke is a leading urologic surgeon and researcher whose work centers on advancing the surgical and minimally invasive management of prostate cancer and benign prostatic hyperplasia (BPH). His major contributions focus on optimizing outcomes for robot-assisted radical prostatectomy (RARP), particularly in complex patient populations. He has pioneered techniques to reduce surgical complications, most notably demonstrating in the landmark ProLy trial (34 citations) that bilateral peritoneal flaps significantly decrease lymphocele incidence after RARP with pelvic lymph node dissection. His research also explores functional recovery, including predictive modeling for erectile function restoration using tadalafil (28 citations), and systematically evaluates the impact of age, obesity, and prior BPH surgery on perioperative and oncological results. Dr. Oelke has further developed evidence-based management algorithms for radiation-induced urethritis and cystitis. With over 20 citations on several key papers, his work has directly shaped clinical practice, improving quality of life and symptom burden for thousands of prostate cancer patients. His high-volume center studies, involving thousands of men, provide robust evidence that guides surgical decision-making for older and higher-risk patients.

Research Focus

Key Achievements

9
H-Index
12
Papers
229
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia
44 citations · 2020
📈 Most Prolific Year: 2022 (5 Papers)
🤝 Key Collaborators: 46
🏛 Institutions: St.-Antonius-Hospital Gronau, Medizinische Hochschule Hannover

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago